Therapeutic delivery systems need to focus on cellular precision to target neurodegeneration
by Lavanya Gupta, Sinem Agilkaya, Kim Susann Keller, Ebru Ercan-Herbst The central problem when delivering drugs to the brain is no longer crossing the blood–brain barrier, but delivering therapeutics to the right cells, in the right regions to target neurodegeneration, within a dynamically changing neurovascular unit.